NN Investment Partners Holdings’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,079,648
Closed -$178M – 889
2021
Q2
$178M Buy
1,079,648
+3,528
+0.3% +$589K 0.95% 26
2021
Q1
$165M Sell
1,076,120
-330,073
-23% -$44.8M 0.97% 21
2020
Q4
$176M Sell
1,406,193
-10,427
-0.7% -$1.17M 1.07% 20
2020
Q3
$144M Sell
1,416,620
-60,460
-4% -$6.16M 0.93% 22
2020
Q2
$144M Buy
1,477,080
+36,284
+3% +$3.38M 0.97% 23
2020
Q1
$120M Buy
1,440,796
+270,471
+23% +$26.4M 0.98% 20
2019
Q4
$130M Buy
1,170,325
+279,041
+31% +$28.7M 0.88% 23
2019
Q3
$88.4M Buy
891,284
+30,815
+4% +$3.06M 0.69% 27
2019
Q2
$85.3M Buy
860,469
+40,436
+5% +$3.86M 0.68% 31
2019
Q1
$90.4M Buy
820,033
+66,458
+9% +$6.95M 0.71% 25
2018
Q4
$69.3M Buy
753,575
+476,575
+172% +$48.2M 0.59% 37
2018
Q3
$30.5M Sell
277,000
-33,000
-11% -$3.44M 0.22% 103
2018
Q2
$28.9M Sell
310,000
-3,000
-1% -$258K 0.21% 108
2018
Q1
$26M Buy
+313,000
New +$27.8M 0.19% 130

Other funds holding PRAH

NN Investment Partners Holdings's PRAH Position: Q3 2021 in Review

NN Investment Partners Holdings sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,079,648 shares — an estimated $178M sold.

NN Investment Partners Holdings first reported a position in PRAH in Q1 2018 and held it in 14 quarters. The position peaked at $178M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • NN Investment Partners Holdings reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • NN Investment Partners Holdings sold 1,079,648 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $178M.
  • NN Investment Partners Holdings first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 14 quarters.
  • NN Investment Partners Holdings's PRA Health Sciences, Inc. position peaked at $178M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on NN Investment Partners Holdings's 13F filing for Q3 2021, filed 10 Nov 2021.